Rapid Micro Biosystems, Inc. (RPID)
|Net Income (ttm)||-51.17M|
|Trading Day||July 27|
|Day's Range||20.32 - 21.46|
|52-Week Range||18.42 - 24.76|
LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutio...
Rapid Micro Biosystems, Inc. has filed to go public with an IPO on the NASDAQ.
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. We are leading a global transformation toward fully automated microbial quality control within pharmaceutical manufacturing. Our flagship Growth Direct platform brings the quality control lab to the manufacturing floor, unlocking the power of in-line/at-the-line... [Read more...]
Laboratory Analytical Instruments
|IPO Date |
Jul 15, 2021
|Stock Exchange |
|Ticker Symbol |
In 2020, RPID's revenue was $16.08 million, a decrease of -2.63% compared to the previous year's $16.51 million. Losses were -$37.08 million, 75.1% more than in 2019.